These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. OKT3 first-line treatment of acute rejection episodes following combined pancreas and kidney transplantation. Cantarovich D; Hourmant M; Dantal J; Giral M; Paineau J; Karam G; Soulillou JP Transplant Proc; 1994 Apr; 26(2):549. PubMed ID: 8171548 [No Abstract] [Full Text] [Related]
17. ATG versus OKT3 in the treatment of steroid-resistant rejection following living-related donor renal transplantation. Uslu A; Tokat Y; Ok E; Unsal A; Ilkgul O; Kaplan H Transplant Proc; 1997 Nov; 29(7):2805-6. PubMed ID: 9365571 [No Abstract] [Full Text] [Related]
18. Comparison of adjusted-dose vs standard-dose OKT3 therapy of acute rejection in pediatric kidney transplant recipients. Piatosa B; Grenda R; Prokurat S Transplant Proc; 1993 Aug; 25(4):2574. PubMed ID: 8356675 [No Abstract] [Full Text] [Related]
19. Combined pancreas-kidney transplantation versus kidney transplantation alone: analysis of benefit and risk. Stratta RJ; Taylor RJ; Ozaki CF; Bynon JS; Langnas AN; Shaw BW Transplant Proc; 1993 Feb; 25(1 Pt 2):1298-301. PubMed ID: 8442119 [No Abstract] [Full Text] [Related]
20. Use of tacrolimus as the primary immunosuppression after renal transplant in Native Americans and Hispanics. Eghtesad B; Malhotra D; Hecker WP; Haq M; Gibel LJ; Wheeler D; Smith AY; Harford AM Transplant Proc; 1998 Jun; 30(4):1232-3. PubMed ID: 9636500 [No Abstract] [Full Text] [Related] [Next] [New Search]